SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$24.23
+0.23 (+0.96%)
Open$24.00
Previous Close$24.00
Day High$25.44
Day Low$24.00
52W High$22.73
52W Low$8.58
Volume—
Avg Volume1.32M
Market Cap1.90B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+1.1% upside
Current
$24.23
$24.23
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 176.96M | 42.66M | 332.47M |
| Net Income | -293,056,550 | -516,701,989 | -96,723,913 |
| Profit Margin | -165.6% | -1,278.8% | -29.1% |
| EBITDA | -281,698,597 | -581,608,963 | -125,567,751 |
| Free Cash Flow | — | — | -63,645,585 |
| Rev Growth | — | -44.7% | -3.0% |
| Debt/Equity | 5.32 | 1.19 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |